ICMR Director General Balrama Bhargava on Monday recommended the use of hydroxy-chloroquine for treating healthcare workers tackling the suspected or confirmed coronavirus cases and also the asymptomatic household contacts of the lab-confirmed cases.
The treatment protocol recommended by the National Task Force has been approved by the Drug Controller General of India (DGCI) for restricted use in emergency situations.
Commenting on the lockdown initiated by several states to contain the coronavirus infection, a health ministry official said the states have been told to order superintendents of police and district magistrates to enforce the lockdown strictly.
"Partial lockdown defeats the purpose of breaking the chain of transmission of novel coronavirus," the official said.
On private laboratories being allowed to conduct testing for COVID-19, Bhargava said 12 private-lab chains have been registered and have started working after being allowed the testing.
These 12 labs have 15,000 collection centres, he said.
So far the country has reported 415 cases, the health ministry officials said, adding the death toll stands at seven.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)